Press Releases HCW Biologics Inc.

Equities

HCWB

US40423R1059

Market Closed - Nasdaq Other stock markets 02:00:01 14/05/2024 am IST			5-day change	1st Jan Change
1.12 ^USD	-0.88%		-12.50%	-8.57%

01/04	HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/04	HCW Biologics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights	02/04	AQ
HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights	14/11	AQ
Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting	08/11	GL
HCW Biologics : First-in-Human Clinical Readout of HCW9218, SITC 2023	06/11	PU
Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting	01/11	GL
HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023	06/23/06	GL
HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights	11/23/11	AQ
HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders	14/23/14	AQ
HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	09/23/09	AQ
HCW BIOLOGICS INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	09/23/09	AQ
HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights	09/23/09	AQ
HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan	27/23/27	GL
HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan	27/23/27	AQ
HCW BIOLOGICS INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	27/23/27	AQ
HCW Biologics Poster Presentation at AACR Annual Meeting 2023	13/23/13	AQ
A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases	03/23/03	AQ
HCW BIOLOGICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	29/23/29	AQ
HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights	29/23/29	AQ
HCW Biologics Enters CRADA with National Cancer Institute	08/22/08	GL
HCW Biologics : Other Event - Form 8-K	07/22/07	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases HCW Biologics Inc.

Equities

HCWB

US40423R1059

Press Releases

Filters